Literature DB >> 27375335

Upshaw-Schulman Syndrome.

B M John1, D Singh2, B Ravichander3, R Madan4, T S Raghu Raman5.   

Abstract

Entities:  

Keywords:  Congenital thrombotic thrombocytopenic purpura; von Willebrand factor cleaving protease

Year:  2011        PMID： 27375335      PMCID： PMC4920926          DOI： 10.1016/S0377-1237(10)80149-2

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  8 in total

Review 1.  Thrombotic thrombocytopenic purpura and its diagnosis.

Authors:  A Veyradier; D Meyer
Journal:  J Thromb Haemost       Date:  2005-05-09       Impact factor: 5.824

Review 2.  Clinical practice. Thrombotic thrombocytopenic purpura.

Authors:  James N George
Journal:  N Engl J Med       Date:  2006-05-04       Impact factor: 91.245

3.  Congenital thrombotic thrombocytopenic purpura: Lessons for recognition and management of rare syndromes.

Authors:  James N George
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

Review 4.  Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children.

Authors:  Chantal Loirat; Agnès Veyradier; Jean-Pierre Girma; Anne-Sophie Ribba; Dominique Meyer
Journal:  Semin Thromb Hemost       Date:  2006-03       Impact factor: 4.180

5.  Two generations with familial thrombotic thrombocytopenic purpura.

Authors:  R G Rodrigues
Journal:  Int J Clin Pract       Date:  2006-01       Impact factor: 2.503

Review 6.  Thrombotic thrombocytopenic purpura.

Authors:  B Lämmle; J A Kremer Hovinga; L Alberio
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

Review 7.  Platelets: thrombotic thrombocytopenic purpura.

Authors:  James N George; J Evan Sadler; Bernhard Lämmle
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

8.  Thrombotic thrombocytopenic purpura in a newborn.

Authors:  Paul T Jubinsky; Richard Moraille; Han-Mou Tsai
Journal:  J Perinatol       Date:  2003-01       Impact factor: 2.521
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.